|Bid||89.92 x 800|
|Ask||89.86 x 800|
|Day's Range||89.22 - 90.02|
|52 Week Range||64.55 - 106.86|
|Beta (3Y Monthly)||1.28|
|PE Ratio (TTM)||41.46|
|Forward Dividend & Yield||3.30 (3.93%)|
|1y Target Est||91.51|
Anheuser-Busch responded to MillerCoors' lawsuit about the controversial Bud Light ad that started airing during the Super Bowl.
Constellation Brands is boosting its U.S. beer business while betting that marijuana products will deliver big sales.
Beer drinking is so ingrained in British life that any mention of choosing non-alcoholic versions of the stuff provokes ire. What is the point of drinking beer without booze in it, the sceptics ask, while ...
Anheuser-Busch InBev has enlisted Citigroup and Bank of America Merrill Lynch (BAML) to the team of banks working on the sale of its Asia-Pacific business, three people with direct knowledge of the matter told Reuters. "There is, however, no decision as to whether we might undertake an IPO or any other potential transaction relating to our Asia Pacific business," AB InBev said, adding it was committed to being a long-term investor in the region.
Anheuser-Busch InBev has enlisted Citigroup and Bank of America Merrill Lynch (BAML) to the team of banks working on the sale of its Asia-Pacific business, three people with direct knowledge of the matter told Reuters. The world's biggest brewer, whose brands include Budweiser, Corona and Stella Artois, said it had always looked at opportunities to optimize its business. "There is, however, no decision as to whether we might undertake an IPO or any other potential transaction relating to our Asia Pacific business," AB InBev said, adding it was committed to being a long-term investor in the region.
Craft brewers shared their thoughts on a 2018 report which showed that the industry is continuing to grow, albeit slower than it has in recent years.
Patagonia beer may sound like it would be extremely profitable to the outdoors apparel brand, but these brews are being sold by Anheuser-Busch (NYSE:BUD), which has led Patagonia to file a lawsuit against the Budweiser parent company.Source: FlickrThe clothing company decided to file a lawsuit after discovering that Anheuser-Busch has been selling a Patagonia-branded beer that also contains the latter's environmentally friendly logo. The beer giant received the trademark to begin selling Patagonia beer in the U.S. in 2012, but the company sat on the name until 2018, which is when it started selling beer with the branding.Patagonia is accusing Anheuser-Busch of trademark infringement as the company claims the latter copied the brand's name and aesthetic. The Patagonia beer packaging has a silhouette of a mountain to go along with the word Patagonia in bold lettering. Making matter worse is that Patagonia claims that Anheuser-Busch has been selling the beer and the clothing company's branded apparel at pop-up stores at ski resorts, which is technically Patagonia clothing territory, according to the suit.InvestorPlace - Stock Market News, Stock Advice & Trading Tips"In short, AB has done everything possible to make it appear as though this PATAGONIA beer is sold by Patagonia." The company added that Anheuser-Busch "has gone as far as creating a logo that is strikingly similar to Patagonia's famous mountain silhouette logo that has appeared continuously for decades on millions of products."BUD stock is up 0.7% Thursday. More From InvestorPlace * 8 Risky Stocks to Watch as Earnings Season Kicks Off * 7 AI Stocks to Watch with Strong Long-Term Narratives * 10 Dow Jones Stocks Holding the Blue Chip Index Back Compare Brokers The post Patagonia Beer? Why the Clothing Company Is Suing Anheuser-Busch appeared first on InvestorPlace.
Patagonia Inc. has filed a lawsuit against Anheuser-Busch InBev claiming the beer giant is copying the outdoor clothing company's name and logo on one of its beers.
Outdoor apparel company Patagonia is suing Anheuser-Busch InBev over the brewer's Patagonia beer. Patagonia has been brewing its own beer since 2016. AB InBev is also being sued by MillerCoors, which alleges that its rival used misleading advertising to trick consumers and infringe on its trademark.
How Analysts Reacted to Constellation Brands’ Q4 Results(Continued from Prior Part)Valuation rises post Q4 resultsConstellation Brands’ (STZ) 12-month forward PE multiple increased 7.2% to 21.2x on April 4, the day the company announced its
For the first time since Tivoil Brewing began making beer again in 2015, a member of the family that owned it at the time of its original closing in 1969 was brewing there.
How Analysts Reacted to Constellation Brands’ Q4 ResultsAnalysts’ reaction to results Constellation Brands (STZ) announced better-than-expected results for the fourth quarter of fiscal 2019 on April 4 backed by the strength in its beer business.
AT&T (Total debt: $177b)AT&T Inc.’s mega-acquisitions of DirecTV in 2015 and Time Warner in 2018 were largely responsible for making it the world’s biggest nonfinancial corporate borrower. The Dallas-based telecommunications carrier, which made debt reduction its “top priority” this year, plans to pay down about $20 billion with internally generated cash flow and proceeds from asset sales. SoftBank ($154b)Masayoshi Son’s SoftBank Group Corp. almost quadrupled its debt, to more than $150 billion, over five years with investments in hot startups such as Uber Technologies Inc. and its purchase of the U.K.’s ARM Holdings.
It's tough to find cannabis stocks with reasonable valuations nowadays. But, hey, when it comes to Tilray (NASDAQ:TLRY), the share price is certainly much more interesting. During the past year, TLRY stock has been chopped from $300 to below $60.If nothing else, this shows how volatile the category is.Yet despite the plunge, TLRY stock is still sporting a market cap of $5.74 billion. And yes, the valuation is far from cheap, such as in terms of the price-to-sales multiple. It's at over 130x!InvestorPlace - Stock Market News, Stock Advice & Trading TipsNow it's true that TLRY stock is among the premier operators in the industry. Consider that the company has a global platform, with presence in countries like Australia, Germany, the U.K., South Africa, Chile, Argentina and, of course, Canada.Tilray stock also has the benefit of an experienced management team, which has shown a penchant for aggressive deal making. In fact, they have been savvy in creating partnerships and acquiring companies to gear up for the CBD opportunity that is likely to see lots of growth in the U.S. The reason is the passage of the farm bill that has taken CBD compounds off the illegal substance list.While all this is great, there are still some nagging issues for Tilray stock. None are reasons on their own to avoid the shares. However, I think there are better alternatives like Cronos Group (NASDAQ:CRON) and Canopy Growth (NYSE:CGC). * 8 Best Stocks to Buy for an April Rally What are some of the problems with Tilray stock? Let's take a look at two that stand out: Small Deals Highlight Scale ConcernsWhile the cannabis market holds enormous potential, the winners will likely need significant scale. Part of this will be to have a large base of production -- allowing for economies of scale -- as well as having the resources to create branded products.CRON and CGC have entered multi-billion dollar partnerships with mega operators like Constellation Brands (NYSE:STZ) and Altria Group (NYSE:MO). These deals have been more than just money. They also have the advantages of leveraging existing distribution channels, brands and consumer products expertise.Tilray, however, has only struck small deals, albeit with big names, such as with Anheuser-Busch Inbev (NYSE:BUD) and Novartis (NYSE:NVS). Small deals could prove to be a limiting factor as the company may not have the resources to compete against its fierce rivals. Can't Meet Canada Demand on Its OwnRight now, the mega-growth opportunity is in Canada, as the country legalized cannabis for recreational use in October. The result is that Tilray has gotten supercharged. In the fourth quarter, revenues soared by 203.8% to $15.5 million.But there is a problem: Production has not been impressive. For Q4 the company reported 2,053 kilos, far below its major peers. CGC pumped out more than 10,000 kilos and Aurora Cannabis (NYSE:ACB) brought forward more than 7,000 kilos. Keep in mind that Tilray was not even in the top four in the market.To make up for the shortfall, the company has been relying on third-party providers. That's gotta put a squeeze on margins. * 7 Biometric Stocks to Watch as AI Rises Here's what CEO Brendan Kennedy had to say on the latest earnings call: "The United States and European markets are orders of magnitude larger than Canada. So, while Canada will continue to be an important market for us, we expect to focus the majority of future investments on the U.S. and Europe. We will not purchase or invest in what we believe to be overpriced supply assets in Canada, which we believe will erode in value in the medium to long term, as the market normalizes."In the meantime, Tilray stock value continues to erode, having lost 57.5% since Canada legalization as compared to a 7.84% decline for ETFMG Alternative Harvest ETF (NYSEArca:MJ), which counts TLRY stock as its fifth-largest holding of a 33-name portfolio.Kennedy approach may be the right one. But it could mean that Tilray will see decelerating growth, as it will take time to ramp up in the U.S. and European markets.TLRY stock investors may not be willing to wait around.Tom Taulli is the author of High-Profit IPO Strategies, All About Commodities and All About Short Selling. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 9 Stocks That Would Be Hurt By a Mexico/U.S. Border Closure * 7 A-Rated Healthcare Stocks for Industry Expansion * 10 Stocks That Every 30-Year-Old Should Buy and Hold Forever Compare Brokers The post Tilray Stock Poses Some Nagging Issues As Legal Cannabis Expands appeared first on InvestorPlace.
The world's largest airlines did a deep dive into beer consumption on board its flights (and in airport lounges) and came up with some surprising findings.
shares were up 1.3% on Friday to $86.13 after the beer maker was upgraded to neutral from underperform at Bank of America Merrill Lynch as the firm said that the company's story is changing as headwinds don't look so daunting. Bank of America analyst Fernando Ferreira said concerns remain about company's high debt levels but noted that Ferreira notes that the maker of Budweiser has made an effort to lower its leverage.
Anheuser Busch Inbev NV (NYSE: BUD ) has a better debt picture, but beer sales, particularly of “mainstream beer,” are still going flat, Bank of America Merrill Lynch said Friday. The Analyst Analyst ...
AB InBev was rising following an upgrade from Bank of America Merrill Lynch, which argued that the “narrative has changed” on the shares.
As a long-time follower of cannabis stocks, I've long held the belief that the best long-term pick in the marijuana industry is Canopy Growth (NYSE:CGC). Multiple things factor into that belief. But, above else, it always comes back to the following: Canopy scored a $4 billion investment from Constellation Brands (NYSE:STZ) in mid-2018, and that $4 billion makes all the difference in terms of having the financial resources to grow into the global cannabis leader.Source: Shutterstock Fast forward to April 2019. Over the past eight months, Canopy has illustrated in a convincing way that $4 billion is a big difference maker in the marijuana industry. With that money, the company has expanded its growth footprint, rolled out new products, jumped into the U.S. market, made big acquisitions, further delved into overseas markets and extended its leadership position in the Canadian market.In other words, Canopy is taking the $4 billion from Constellation Brands, and it is strategically using it to create a viable pathway for this company to one day become the Altria (NYSE:MO) or Anheuser-Busch (NYSE:BUD) of the global cannabis market.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThose companies have $100 billion-plus market capitalizations in the global tobacco and alcoholic beverage markets, respectively. The recreational cannabis market projects to be as large as those markets one day. * 10 Medical Marijuana Stocks to Cure Your Portfolio Add in the medical cannabis market, and the whole cannabis market should be even bigger than the tobacco and alcoholic beverage markets. As such, the Altira or Anheuser-Busch of cannabis will easily one day be a $100 billion-plus company.Big picture? Thanks to an early lead, big resources and strong investments, CGC stock remains on track to be a $100 billion-plus company one day. What Is CGC Doing With $4 Billion?The global cannabis market is early stage. When it comes to early-stage markets, the key to success is investing to grow. The company best positioned to do that? CGC.While a few other Canadian cannabis producers have scored some big investments from large consumer staples companies, none have scored anything like the $4 billion investment Constellation Brands made in Canopy. As such, CGC stock naturally has more investment firepower than anyone else in the industry.But, investment firepower doesn't mean much unless you invest wisely. CGC has done just that. Just take look at all these investments, partnerships and expansions Canopy has made in the past month alone: * Canopy partnered with new Canadian cannabis brand Houseplant, which is led by Hollywood stars Seth Rogen and Evan Goldberg. * The company launched a new production facility that projects to increase annual cannabis output by 5,000 kilograms. * The company also acquired AgriNextUSA, a U.S. hemp company that projects to help Canopy grow its presence in the U.S. hemp market following the passage of the 2018 Farm Bill. * Canopy has extended partnerships with cannabis brands Hollyweed and DNA Genetics. * The NHL Alumni Association has teamed up with Canopy to research CBD and its potential use as a concussion treatment.That's all in the past month. Go back eight months, and you'll see all the same stuff, at eight-fold the volume, with the recurring themes being cannabis-brand partnerships, production facility expansions, CBD research collaborations and U.S. market-specific growth initiatives.In other words, CGC is utilizing its unparalleled investment firepower to make strategic investments, partnerships and expansions that best position the company to maintain and even extend its global cannabis market leadership. Cannabis Market Leadership Is a Valuable PositionThe global recreational cannabis market best parallels to the global tobacco and alcoholic beverage markets. All three substances are loosely classified and perceived as largely benign "drugs," and consumption of all three is very prevalent today.The only difference is legality. But, trends are already moving in favor of legal cannabis worldwide. When that happens, current consumption trends imply that the global cannabis market will be as big as the global alcoholic beverage and tobacco markets. Each of those markets has produced several $100 billion-plus companies. Thus, the recreational cannabis market projects to produce several $100 billion-plus companies, too.That's not even considering the medicinal side of this market, which many think will be larger than the recreational market.Consequently, it's easy to see that whoever turns into the global cannabis market leader, will ultimately be a very big, very valuable company. Right now, the most likely pick to be that leader is CGC. Considering that the company still has roughly $3 billion in cash on the balance sheet, it seems likely that CGC will remain the most likely pick to be the global leader for a long time. Bottom Line on CGC StockCanopy Growth stock has been the best pick in the red-hot cannabis sector because of a $4 billion investment from Constellation Brands, which gave the company unparalleled investment firepower to extend its market leadership position. * 7 Energy ETFs That Could Be Running Out of Fuel The company has done just that, and with $3 billion still left on the balance sheet, this growth narrative is still in its first few innings.As of this writing, Luke Lango was long CGC stock. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 9 Stocks That Would Be Hurt By a Mexico/U.S. Border Closure * 7 A-Rated Healthcare Stocks for Industry Expansion * 10 Stocks That Every 30-Year-Old Should Buy and Hold Forever Compare Brokers The post $4 Billion Matters. Just Ask Canopy Growth appeared first on InvestorPlace.
Constellation Brands (NYSE:STZ) reported earnings this morning and initially Wall Street liked what they saw. STZ stock spiked on the headlines but has faded. So now the job for the bulls today is to hold the line so they can build further upside on a strong report.Source: Shutterstock Management's scorecard shows that they easily beat estimates fueled by strong Corona and Modelo beers. The wine sales, on the other hand, were weak but management has already acted to remedy this shortfall.Maybe it was a sign that they expected drama over the wine weakness this morning, but they broke some pertinent news. Just after the market closed on Wednesday, we learned that Constellation Brands is looking to divest 30 of their lower-priced wine and spirits brands to Gallo for about $1.7 billion.InvestorPlace - Stock Market News, Stock Advice & Trading TipsAlthough this was less than what there were seeking for it, this should ease investor concerns about the sales miss this quarter. And this will put a nice pile of cash back onto their balance sheet. * 7 Biometric Stocks to Watch as AI Rises Coming into the report STZ is up 12% year-to-date, just trailing the S&P 500. So there is some room to give back here but the stock ranges are tight. STZ stock has just finally recovered from their last earnings debacle so they can't afford another letdown here.It's not that they delivered a stinker of a report. Net sales did fall relative to last year, but they did beat the analyst estimates. What's important is that they improved their bottom line as net income per share sprang almost 40% from a year ago. So clearly management is executing on plans very well.However, and as is the case in every dip on earnings these days, management committed the cardinal sin of earnings events. They guided lower for the coming quarter. Investors have no tolerance for that these days and that's almost all that matters to them for the short term.We often see perfect quarters trigger big selloffs if the guidance is weak. But STZ management is not worried they are merely being cautious in a time when we have so many geopolitical worries still looming. If they were truly worried they wouldn't raise dividends or continue buybacks. They simply want to under promise and over deliver.This is a proven management team and they are not afraid to take risks. They were first of the mega-cap companies to invest in the cannabis pot of gold. They dumped $4 billion into Canopy Growth (NYSE:CGC) and risk this size is proof that they can commit to potential when they see it.Fundamentally, Constellation Brand stock is cheap. It sells at a price-to-earnings ratio of 13x, which is twice as cheap as Anheuser-Busch (NYSE:BUD) or Coke (NYSE:KO). So owning its shares here is not a giant financial risk.We all know that 2018 ended badly for stocks. Christmas marked the bottom for the most of them and since then we've recovered almost all of it. However, STZ did not bottom until Jan. 9. The good news is that since, STZ stock clawed its way up 20% from the abyss. Along the way, the $175 per share zone was important.Just the same, the zone above this morning's pop is also important. It is a prior pivot point that dates back two years. So these are resistance on the way back up. So the Constellation stock bulls have work to do. Breaking through $188 area will not be easy but if management can continue to deliver strong results it will be doable.The weekly chart shows that the STZ stock breaching $177 per share started a rally that has more upside in it so they are on their way. The close today will be important to maintain this momentum. There is nothing to sustain concerns in today's report so it's not likely that there will be big sellers here.There is support below but it needs to hold. Losing the $160 per share zone create a major technical problem for the bulls. While this is not a forecast and definitely not my expectation, it is a realistic scenario that does exist. * 5 Low-Priced Tech Stocks With Great Potential The experts on Wall Street agree because most analysts who cover the stock rate it as a buy. So for those who own the shares for the long-term need not worry about any short term stock gyrations since management is doing its job well.Nicolas Chahine is the managing director of SellSpreads.com. As of this writing, he did not hold a position in any of the aforementioned securities. You can follow him as @racernic on Twitter and Stocktwits. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 Low-Priced Tech Stocks With Great Potential * 9 Stocks That Would Be Hurt By a Mexico/U.S. Border Closure * The Era of Car Ownership Is Over. And These 4 Charts Prove It Compare Brokers The post Wall Street Can Toast the Constellation Brands Report appeared first on InvestorPlace.